Clinical trial
Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™…
NCT00423371 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00423371 |
|---|---|
| Title | Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC |
| Official title | A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of EUFLEXXA™ for Treatment of Osteoarthritis (OA) of the First Carpometacarpal (CMC) Joint |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Device |
| Interventions | sodium hyaluronate, placebo |
| Enrollment | 79 |
| Start date | Dec 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Jan 18, 2007 |
| Last update posted | May 19, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: